Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
Citations Over TimeTop 18% of 2011 papers
Abstract
Utilizing a fully synthetic route to tetracycline analogues, the C-9 side-chain of the fluorocyclines was optimized for both antibacterial activity and oral efficacy. Compounds were identified that overcome both efflux (tet(K), tet(A)) and ribosomal protection (tet(M)) tetracycline-resistance mechanisms and are active against Gram-positive and Gram-negative organisms. A murine systemic infection model was used as an oral efficacy screen to rapidly identify compounds with oral bioavailability. Two compounds were identified that exhibit both oral bioavailability in rat and clinically relevant bacterial susceptibility profiles against major respiratory pathogens. One compound demonstrated oral efficacy in rodent lung infection models that was comparable to marketed antibacterial agents.
Related Papers
- → Epigallocatechin-Gallate Enhances the Activity of Tetracycline in Staphylococci by Inhibiting Its Efflux from Bacterial Cells(2004)256 cited
- → Plasmid-mediated tetracycline resistance in escherichia coli involves increased efflux of the antibiotic(1980)108 cited
- → A tetracycline efflux gene on Bacteroides transposon Tn4400 does not contribute to tetracycline resistance(1990)20 cited
- → Screening of an Inhibitor of the Tetracycline Efflux Pump in a Tetracycline-Resistant Clinical-Isolate of Staphylococcus aureus 743.(1998)15 cited